Kathleen Lokay on How Data Generation Informs Clinical Pathways

Digital utilization can generate data with supporting evidence for clinical pathways that benefits clinicians, explained Kathleen Lokay, president and CEO of Via Oncology.

Digital utilization can generate data with supporting evidence for clinical pathways that benefits clinicians, explained Kathleen Lokay, president and CEO of Via Oncology.

Transcript

How does digital data collection and utilization impact decision making for providers?

As I think about it in the light of clinical pathways, really the digital utilization of clinical pathways, helps the clinicians keep up with clinical evidence, pick treatments for their patients that are high value, really stay abreast of current information. The data generated from that is what is also interesting because then that data informs not only that the physicians was on or off pathway but actually helps the next iteration of that pathway.

So the committees who develop the pathways can learn from the data that is collected by utilizing the pathways so the decision support is actually then in the future really a contributor to the data because it informs whether or not the physicians felt that the pathway was adequate for the patients so it’s an inner cycle.